News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Biotron.
RELATED STOCKHEAD STORIES
News
ASX September winners: August was rough. September was brutal
Health & Biotech
ASX Biotech September Winners: Healthcare down 5pc, but experts say it’s still best sector in a recession
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: ASX trips at starting gun while US Futures jump on world not ending yet
News
ASX Small Caps Lunch Wrap: Who’s been stocking up on gold at Costco this week?
News
Market Highlights: ASX Futures down after a wild weekend in Washington, and 5 ASX small caps to watch today
News
Hot Money Monday: These are the top momentum stocks; and introducing the Simple Moving Average
News
Traders’ Diary: 11th hour agreement in Washington could be harbinger of October bloom
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: ASX’s September Shocker ends on a win as uranium spot clocks 15-yr high
News
ASX Small Caps and IPO Weekly Wrap: Things went better than expected in a week all about lithium and uranium
News
ASX Small Caps Lunch Wrap: Who’s marking the end of a home-delivered era today?
News
Top 10 at 11: It’s a mixed up kinda morning, but we’re moving in the right direction… for now
Health & Biotech
Check Up: How supramolecular technology is used in biotech, and why L’Oréal wants to get its hands on it
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Local markets fall on timid Tuesday but Biotron bets build as investors ask if it’s aced an anti-viral AIDS therapy
News